These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11365843)

  • 21. Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.
    Delaugerre C; Warszawski J; Chaix ML; Veber F; Macassa E; Buseyne F; Rouzioux C; Blanche S
    J Med Virol; 2007 Sep; 79(9):1261-9. PubMed ID: 17607781
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intermittent viremia during first-line, protease inhibitors-containing therapy: significance and relationship with drug resistance.
    Masquelier B; Pereira E; Peytavin G; Descamps D; Reynes J; Verdon R; Fleury H; Garraffo R; Chêne G; Raffi F; Brun-Vézinet F;
    J Clin Virol; 2005 May; 33(1):75-8. PubMed ID: 15797369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiretroviral resistance among HIV-infected persons who have died in British Columbia, in the era of modern antiretroviral therapy.
    Recsky MA; Brumme ZL; Chan KJ; Wynhoven B; Yip B; Dong WW; Heath KV; Montaner JS; Levy AR; Hogg RS; Harrigan PR
    J Infect Dis; 2004 Jul; 190(2):285-92. PubMed ID: 15216463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence for differences in the sexual transmission efficiency of HIV strains with distinct drug resistance genotypes.
    de Mendoza C; Rodriguez C; Corral A; del Romero J; Gallego O; Soriano V
    Clin Infect Dis; 2004 Oct; 39(8):1231-8. PubMed ID: 15486849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term virological outcome and resistance mutations at virological rebound in HIV-infected adults on protease inhibitor-sparing highly active antiretroviral therapy.
    de la Rosa R; Ruíz-Mateos E; Rubio A; Abad MA; Vallejo A; Rivero L; Genebat M; Sánchez-Quijano A; Lissen E; Leal M
    J Antimicrob Chemother; 2004 Jan; 53(1):95-101. PubMed ID: 14657091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CDC: avoid preventive therapy for sexual risk. Centers for Disease Control and Prevention.
    AIDS Alert; 1996 Jul; 11(7):75-6. PubMed ID: 11363548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Update on HIV/AIDS in Thailand.
    Ruxrungtham K; Phanuphak P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S1-17. PubMed ID: 11529320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding transmitted HIV resistance through the experience in the USA.
    Taiwo B
    Int J Infect Dis; 2009 Sep; 13(5):552-9. PubMed ID: 19136289
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission.
    Delaugerre C; Morand-Joubert L; Chaix ML; Picard O; Marcelin AG; Schneider V; Krivine A; Compagnucci A; Katlama C; Girard PM; Calvez V
    Antivir Ther; 2004 Jun; 9(3):415-21. PubMed ID: 15259904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens.
    Maggiolo F; Ripamonti D; Torti C; Arici C; Antinori A; Quiros-Roldan E; Minoli L; Sighinolfi L; Nasta P; Suter F;
    Antivir Ther; 2006; 11(7):923-9. PubMed ID: 17302255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Barebacking no more: transmission of resistant HIV strains a reality.
    Arroyo H
    Newsline People AIDS Coalit N Y; 1998 Sep; ():18-9. PubMed ID: 11367484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protease inhibitors work against HIV-1 subtype C.
    AIDS Alert; 1999 May; 14(5):suppl 2, 4. PubMed ID: 11366406
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Routine surveillance for the detection of acute and recent HIV infections and transmission of antiretroviral resistance.
    Truong HM; Grant RM; McFarland W; Kellogg T; Kent C; Louie B; Wong E; Klausner JD
    AIDS; 2006 Nov; 20(17):2193-7. PubMed ID: 17086059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute pancreatitis associated with different combination therapies in patients infected with human immunodeficiency virus.
    Guo JJ; Jang R; Louder A; Cluxton RJ
    Pharmacotherapy; 2005 Aug; 25(8):1044-54. PubMed ID: 16207094
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Vertical trasmission of human immunodeficiency virus (HIV) and other sexually transmitted infections (STI)].
    Casalini C; Signorini L; Beltrame A; Matteelli A; Carosi G
    Minerva Ginecol; 2001 Jun; 53(3):177-92. PubMed ID: 11395690
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug resistance genotypes predict response to amprenavir-containing regimens in highly drug-experienced HIV-1-infected patients.
    Sabin CA; Wilkins E; Murphy M; Fisher M; de Ruiter A; Easterbrook PJ; Leen C; Vlahakis E; Cane PA; Li X; Pillay D;
    Antivir Ther; 2003 Aug; 8(4):301-8. PubMed ID: 14518699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protease inhibitors reduce virus in sperm.
    AIDS Alert; 1997 Jun; 12(6):69-70. PubMed ID: 11364362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [When should a patient be tested for HIV?].
    Sutinen J
    Duodecim; 2011; 127(10):1027-32. PubMed ID: 21696002
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The sexual transmission of zidovudine-resistant HIV-1 strains].
    Ruiz L; Clotet B
    Med Clin (Barc); 1995 Oct; 105(12):476-7. PubMed ID: 7490942
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical picture and overall status of newly diagnosed HIV patients at Turku University Hospital in 2013.
    Eskola S; Finnilä T; Hohenthal U; Oksi J
    Duodecim; 2016; 132(21):2001-8. PubMed ID: 29190052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.